The Trump administration has decided to further debate the federal rule passed during the Biden administration that ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder ...

A panelist discusses how novel targeted therapies such as antibody-drug conjugates are rapidly evolving in gynecologic ...

Second of 2 parts featuring an interview with Stephen Strickland, MD, MSCI,director, Leukemia Research for Sarah Cannon ...

Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, seem to align with recent bad news for this ...

Haywood, MD, MPH, MMM, Xavier Ochsner College of Medicine, and Toni Flowers, PhD, DHL, MBA, LCMC Health, advocate for understanding individual patient circumstances, ultimately leading to more ...

The move would align prescription costs in the US with the costs of other countries, according to the administration.

Proposed Medicaid cuts in the Republican budget proposal hold significant implications for health care access and coverage.

Stephen Speicher, MD, and Kate Estep, from Flatiron Health, discuss the future of oncology care with artificial intelligence ...

The analysis of 3 dozen studies found similarities and differences in motivating factors for and against clinical trial ...